Three researchers from the "MaxPlanck@TUM" program will receive funding from the European Research Council (ERC). Along with three other members of the Technical University of Munich (TUM) they won ERC Starting Grants in this year’s round of competition. Unique in Germany, "MaxPlanck@TUM" is a program for young professors run by the Max Planck Society and TUM.In ,,MaxPlanck@TUM" excellent young scientists are appointed to lead a Max-Planck research group and in parallel to an Assistant Professorship at TUM. This provides them with outstanding research opportunities and at the same time clear career perspectives in the TUM Tenure Track system: If they receive a positive assessment after a period of six years, the transition to a permanent, higher-paying professorship is guaranteed. Four of the current nine scientists in the "MaxPlanck@TUM" program have now already won an ERC Grant, one of the most important European research subsidies.
This year in TUM engineering sciences Prof. Matthias Nießner, Prof. Antonia Wachter-Zeh und Prof. Majid Zamani had already won ERC Starting Grants. Starting Grants are intended for early-career scientists and are endowed with as much as ¤ 1.5 million. The latest awards bring the total number of ERC Grants received by TUM in various categories to 96 ERC Grants. In detail, that’s 22 Advanced Grants, 21 Consolidator Grants, 45 Starting Grants and 8 Proof of Concept Grants.
In the "MaxPlanck@TUM " programme the following projects have now been awarded:
Prof. Karl DuderstadtThe unique instructions for each organism are stored in DNA. To fit in cells, the DNA is twisted and compacted into chromosomes. During cell division, a large molecular machine, known as the replisome, unpackages and duplicates chromosomes to produce copies for the daughter cells. Mistakes during this process can have disastrous consequences leading to unstable inheritance and underlying many severe human diseases. The structure and operation of the molecular machine that conducts this process is not well understood. Karl Duderstadt, head of the research group "Structure and Dynamics of Molecular Machines", plans to change this by employing cutting edge imaging methods to directly observe these machines in action. These studies will reveal how the vital genetic code of life is faithfully copied and the origin of mistakes that can have disastrous consequences for future generations.
Karl Duderstadt Professor for Experimental Biophysics at TUM and Max Planck Research Group Leader at the MPI for Biochemistry.
Prof. Julijana GjorgjievaHow are neuronal circuits constructed and organized during the early post-natal stage of human development? Prof. Julijana Gjorgjieva addresses this question in her project "NeuroDevo". Together with her team she will apply a combination of data analysis, theory and modeling. Another project objective is ascertaining how neuronal circuits are changed by intact and disturbed sensory activities. In this context Gjorgjieva analyzes longitudinal sectional images of individual neurons and network activities via a synthesis of data from three collaborating laboratories.
Prof. Gjorgjieva’s Team is searching for new aspects of such activity that drive the refinement of circuits over a longer period of time. In addition, the group will investigate how activity and circuit properties mutually influence one another and how individual components impact the organization of circuits.
Julijana Gjorgjieva is Professor for Computational Neuroscience at TUM and Leader of the research Group "Computation in Neural Circuits" at the Max Planck Institute for Brain Research.
Prof. Danny NedialkovaProteine, die molekularen Maschinen der Zellen, führen die große Mehrheit von Prozessen in Zellen aus. Proteine werden aus langen Aminosäureketten hergestellt, müssen sich aber in verschiedene dreidimensionale Formen falten, um ihre Aufgaben zu erfüllen. Fehler in diesem Faltungsprozess können für die zelluläre Gesundheit katastrophale Folgen haben. Fehlgefaltete Proteine sind ein Kennzeichen des Alterns und diverser neurologischer Krankheiten.
An den Ribosomen, den Proteinfabriken der Zelle, wird die Boten-RNA in Aminosäureketten übersetzt. Die Proteine beginnen sich zu falten, sobald sie an den Ribosomen hergestellt werden. Die Arbeitsgruppe unter der Leitung von Prof. Danny Nedialkova möchte verstehen, welche Prozesse während der Boten-RNA-Übersetzung die zelluläre Vielzahl der Proteine entstehen lassen. Das Team will nach verschiedenen Versuchen definieren, wie Proteinsynthese und Faltung in gesunden Zellen zusammenwirken und wie Fehler im System Krankheiten verursacht.
Danny Nedialkova is Professor for Biochemistry of Gene Expression at TUM and Research Group Leader at the MPI for Biochemistry